A very different flavour to our previous conferences
Childhood Cancer 2016 has a very different flavour to our previous conferences, which have focused on the aetiology of childhood cancer. This year we are looking at how new developments in translational science are being harnessed to improve survival and quality of survival for children with cancer. We will start the conference by considering, on day one, the potential of precision medicine
to improve the outlook for children with cancer in the UK, discussing the promise and pitfalls of making DNA sequencing available for all young cancer patients. Children with Cancer UK has recently committed funding to support the preliminary stages of rolling out sequencing across the UK and as part of his day one talk Dr Darren Hargrave will discuss plans for the implementation of this work. On day two, attention will turn to immunotherapy
as we hear from world-leading experts about the remarkable success that is being achieved in the US and here in the UK. On day three we will revisit the question of causation, what is known about influenceable causes of cancer and what steps can realistically be taken to reduce the incidence of cancer in children and young people.